BCG versus isoniazid in the prevention of tuberculosis
Sifontes, J.E.
Boletin de la Asociacion Medica de Puerto Rico 72(3): 111-116
1980
ISSN/ISBN: 0004-4849 PMID: 6930275 Document Number: 166500
Document emailed within 1 workday
Related Documents
Belianin, I.I. 2004: Decreased resistance of multiresistant mycobacteria to isoniazid during the treatment of experimental tuberculosis with ozone and isoniazid Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2004(3): 95-98Gordin, F.; Chaisson, R.E.; Matts, J.P.; Miller, C.; de Lourdes Garcia, M.; Hafner, R.; Valdespino, J.L.; Coberly, J.; Schechter, M.; Klukowicz, A.J.; Barry, M.A.; O'Brien, R.J. 2000: Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group JAMA 283(11): 1445-1450
Farer, L.S.; Long, M.W.; Snider, D.E. 1981: Isoniazid-rifampin regimens for tuberculosis Annals of Internal Medicine 95(4): 518-519
Tamborero, G.; Pérez, A.; Almazán, C. 1986: Control of chemoprophylaxis of tuberculosis with isoniazid Medicina Clinica 87(2): 84
Panić, E. 2004: World Health Organization guidelines for prevention of tuberculosis in healthcare facilities in countries with limited resources (measures for prevention of tuberculosis) Medicinski Pregled 57 Suppl. 1: 69-74
Panić, E. 2004: World Health Organization guidelines for prevention of tuberculosis in healthcare facilities in countries with limited resources (measures for prevention of tuberculosis) Medicinski Pregled 57 Suppl. 1: 69-74
Gurumurthy, P.; Ramachandran, G.; Hemanth Kumar, A.K.; Rajasekaran, S.; Padmapriyadarsini, C.; Swaminathan, S.; Venkatesan, P.; Sekar, L.; Kumar, S.; Krishnarajasekhar, O.R.; Paramesh, P. 2004: Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 38(2): 280-283
O'Brien, R.J.; Long, M.W.; Cross, F.S.; Lyle, M.A.; Snider, D.E. 1983: Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis Pediatrics 72(4): 491-499
Palomera Frade, J.; García del Palacio, J.I. 1985: Antituberculosis prevention with isoniazid Medicina Clinica 85(13): 545-547
Shkurupiĭ, V.A.; Chernova, T.G.; Kurunov, I.N. 1993: Changes in the granuloma in the experimental treatment of tuberculosis with a prolonged form of isoniazid Problemy Tuberkuleza 1993(1): 38-41
Lo Schiavo, A.; Cozzi, R.; Alfano, R.; Romano, F.; La Montagna, M.; Caccavale, T.; Capasso, R.; Mea, E.E.; Caccavale, S. 2014: A case of tuberculosis cutis colliquativa treated with rifampicin and isoniazid Acta Dermatovenerologica Croatica: Adc 22(2): 160-161
Hong, Y.P.; Jin, B.W.; Kim, S.J. 1988: Implications of emerging isoniazid resistance to Mycobacterium tuberculosis in Korea Aviation Space and Environmental Medicine 59(2): 185
Aamodt, T. 1970: Liver function during tuberculosis therapy with streptomycin, isoniazid and aminosalicylate Nordisk Medicin 83(24): 774
Volosevich, G.V. 1989: Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis Problemy Tuberkuleza 9: 72-73
Africanov, I.I. 1979: The effect of high doses of isoniazid on biosynthesis of albunin in experimental tuberculosis East African Medical Journal 56(9): 442-444
Tytor, I.M. 1975: Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis Problemy Tuberkuleza 7: 51-54
Engbaek, H.C.; Larsen, S.O.; Rasmussen, K.N.; Vergmann, B. 1973: Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin Scandinavian Journal of Respiratory Diseases 54(2): 83-91
Gupta, P.; Jadaun, G.P.S.; Das, R.; Gupta, U.D.; Srivastava, K.; Chauhan, A.; Sharma, V.D.; Chauhan, D.S.; Katoch, V.M. 2006: Simultaneous ethambutol and isoniazid resistance in clinical isolates of Mycobacterium tuberculosis Indian Journal of Medical Research 123(2): 125-130
Kibrik, B.S.; Pavlov, A.V.; Zakharov, A.V.; Kreĭtsberg, G.N. 2011: Overcoming resistance of tuberculosis infectious agent by isoniazid-silver nanocomposite Eksperimental'naia i Klinicheskaia Farmakologiia 74(4): 24-26
Chierakul, N.; Saengthongpinij, V.; Foongladda, S. 2014: Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis Journal of the Medical Association of Thailand 97(Suppl 3): S86-S90